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Epidermolysis bullosa simplex (EBS) is a usually autosomal
dominant disorder that results from mutations in the genes
that encode keratin 5 (KRT5) and keratin 14 (KRT14). The
severity of EBS may range from generalized blistering to
localized acral blistering; generalized involvement is often
associated with mucosal blistering, particularly involving the
oropharynx, esophagus, and ocular mucosae. Genotype-
phenotype correlations have been shown in patients with
EBS, with mutations in the end terminal rod domains of
KRT5 and KRT14 leading to the most severe manifestations
of EBS, the so-called Dowling-Meara form. Neonates with
the more severe forms of EBS can be indistinguishable
clinically from neonates with more devastating types,
junctional EB-Herlitz and recessive dystrophic EB. Early
diagnosis based on immunomapping techniques provides
prognostic information during the neonatal period.
Although infants and neonates with severe EBS may
have significant problems because of their generalized
blistering, especially recurrent skin and systemic infections
and nutritional deficits, the blistering of EBS tends to
diminish with advancing age. Older children and adoles-
cents with EBS show no evidence of growth retardation or
anemia, and infants with severe, generalized blistering may
show minimal blistering by adolescence. The tendency
toward greater caution against trauma in older individuals
and the observation of ‘‘compensatory’’ skin thickening at
sites of recurrent blistering have been implicated as reasons
for the significant improvement.
In this issue, Smith et al suggest an alternative explana-
tion: revertant mosaicism, a form of ‘‘natural gene therapy’’
(Smith et al, 2004). In confirming the R125C mutation of
KRT14 from genomic DNA in cultured keratinocytes from a
20-year-old patient with the Dowling-Meara form of EBS, a
second mutation in KRT14 was identified. This mutation
was a frameshift mutation upstream of the R125C mutation,
leading to a premature termination codon that obliterated
the results of the R125C mutation because only the normal
allele produced a viable keratin 14 product. Consistently,
the majority of keratinocytes showed a normal keratin
filament network. Having a mutation that leads to a
termination codon in one allele, as occurs in carrier parents
of individuals with the rare autosomal recessive form of
EBS, results in a normal keratin 14 filament network and no
observable cutaneous abnormality. Smith et al noted the
lack of blistering on the lower abdomen, the site from which
keratinocytes for culture were obtained, and on the trunk,
both locations at which significant blistering had occurred
during childhood. Given the selective advantage of normal
keratinocytes over keratinocytes with dominant negative
mutations in KRT14, as has been shown in mosaic mouse
models (Cao et al, 2001), Smith et al hypothesized that
spontaneous revertant mutations may be an alternative
mechanism for the progressive improvement in patients
with the Dowling-Meara form of EBS.
Infants with generalized blistering at sites of cutaneous
stress that heal without scarring usually have EBS, and the
concomitant involvement of the buccal mucosa and nails
indicates the Dowling-Meara form. Huber et al described
such a patient, thought to have EBS, who unexpectedly
showed subtle alterations in hemidesmosomes and im-
paired attachment of keratin filaments to the hemidesmo-
some plaque (Huber et al, 2002). Immunofluorescence
studies revealed normal staining of keratins and hemides-
mosomal proteins, including the extracellular domain of
BP180/collagen XVII, but an antibody directed against the
intracellular domain of BP180/collagen XVII consistently
showed no staining. Mutational analysis of the COL17A1
gene demonstrated a heterozygous mutation that combined
a mutation leading to a premature termination codon
(R1226X) with a large in-frame deletion mutation that led
to a truncated BP180 protein that lacked Ile-18 to Asn-407
of the intracellular domain. Unlike patients with non-Herlitz
junctional EB and COL17A1 mutations who typically show
large blisters and prominent dental enamel defects, Huber’s
patient lacked dental abnormalities and had mild, grouped
blisters.
In this issue, Fontao et al investigated the functional
consequences of truncation in BP180 in vitro (Fontao et al,
2004). These studies show that BP180 without a significant
portion of its intracellular domain can be effectively re-
cruited into hemidesmosome-like structures in keratino-
cytes and shed from the cell surface, but cannot bind to
BP230, plectin, or beta4 integrin subunits of the hemides-
mosome, thereby leading to cutaneous instability. These
data suggest that mutations that affect the more ‘‘super-
ficial’’ portion of the hemidesmosome that contains the
intracellular domain of BP180 and plectin lead to a milder
phenotype without dental abnormalities. Of interest, muta-
tions in plectin also lead to mild cutaneous blistering with nail
dystrophy, but no dental abnormalities, and, although the
defect is now known to be hemidesmosomal, this subtype
was originally classified as a form of EBS (Gache et al, 1996).
A relatively mild form of EBS, EBS with mottled
pigmentation, manifests as relatively mild acral blistering
Copyright r 2003 by The Society for Investigative Dermatology, Inc.
vi
and the progressive appearance of reticulated hyperpig-
mentation, especially of the trunk, upper arms and neck
beginning during childhood. Mutations in seven families
with this form of EBS have all led to a change in the 24th
amino acid of keratin 5 (P24L) (Uttam et al, 1996). In this
issue, Has and Bruckner-Tuderman describe an adult who
was thought to have EBS with mottled pigmentation as an
adolescent. This diagnosis was based on acral blistering
and the appearance of mottled hyperpigmentation (Bruck-
ner-Tuderman et al, 1989; Has and Bruckner-Tuderman,
2004). Cleavage through the basal cells with clumped
keratin tonofilaments on ultrastructural studies and immu-
nomapping that showed BP230, laminin 5, collagen IV and
collagen VII at the blister floor were also consistent with
EBS with mottled pigmentation. However, by 35 years of
age, the patient showed more evidence of photosensitivity,
mucosal fragility, palmoplantar keratoaderma, and atrophy
of the dorsal aspect of the hands and feet, features of
Kindler syndrome rather than EBS with mottled pigmenta-
tion. Distinguishing Kindler syndrome from EBS has been
difficult for other investigators in the past, particularly when
ultrastructural studies confirm the split through the basal
cell layer and show keratin tonofilament clumping (Haber
and Hanna, 1996). Because of the associated atrophy of the
dorsum of the hands and feet, Kindler syndrome has also
been confused with the dominant dystrophic form of EB,
which results from mutations (usually missense) in COL7A1.
The underlying molecular basis of Kindler syndrome was
recently described by two groups, Jobard et al, who called
the gene kindlerin (Jobard et al, 2003) and Siegel et al, who
called the gene KIND1 (Siegel et al, 2003). The protein
product of this gene, kindlin-1, is thought to mediate the
connection between the actin cytoskeleton and focal
contacts on the keratinocyte cell membrane, providing a
parallel with the function of keratin 5, which is thought to
mediate the attachment of hemidesmosomal proteins to the
cell membrane. Indeed, molecular studies of Has and
Bruckner-Tuderman’s patient showed no mutation in KRT5,
but instead a homozygous G910T mutation in KIND1,
leading to a stop codon (E304X), and confirming molecularly
the diagnosis of Kindler syndrome. Also in this issue, Ashton
et al describe four other new mutations in KIND1, bringing
the total number of mutations known to lead to Kindler
syndrome to 18 (Ashton et al, 2004). Ashton et al emphasize
the value of immunostaining with anti-kindlin-1 antibody,
which shows absence or marked attenuation of kindlin-1 as
a tool for rapidly confirming the diagnosis of Kindler
syndrome.
Our understanding of blistering disorders of skin has
blossomed during the last decade since the original
discovery of the underlying basis for EBS, the first of the
inherited blistering disorders to be linked to gene mutations.
Despite the availability of immunomapping and ultrastruc-
tural techniques to classify patients with this group of
disorders, this group of articles demonstrates well that
molecular analysis will ultimately need to be added to
clinical, immunologic, and ultrastructural evaluations for the
most accurate diagnoses.
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